{"id":"https://openalex.org/W4294010338","doi":"https://doi.org/10.1021/acs.oprd.2c00221","title":"Scalable Process of Spiro(cyclopropane)oxazepane Pyridine Carboxylic Acid through Kulinkovich, Mitsunobu, and Pd-Catalyzed Intramolecular C\u2013N Coupling","display_name":"Scalable Process of Spiro(cyclopropane)oxazepane Pyridine Carboxylic Acid through Kulinkovich, Mitsunobu, and Pd-Catalyzed Intramolecular C\u2013N Coupling","publication_year":2022,"publication_date":"2022-09-01","ids":{"openalex":"https://openalex.org/W4294010338","doi":"https://doi.org/10.1021/acs.oprd.2c00221"},"language":"en","primary_location":{"id":"doi:10.1021/acs.oprd.2c00221","doi":"https://doi.org/10.1021/acs.oprd.2c00221","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.oprd.2c00221","pdf_url":null,"source":{"id":"https://openalex.org/S107255770","display_name":"Organic Process Research & Development","issn_l":"1083-6160","issn":["1083-6160","1520-586X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Organic Process Research & Development","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083311412","display_name":"Bo Qu","orcid":"https://orcid.org/0000-0001-7347-0108","observed_orcids":["https://orcid.org/0000-0001-7347-0108"]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Bo Qu","raw_affiliation_strings":["Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States"],"raw_orcid":"https://orcid.org/0000-0001-7347-0108","affiliations":[{"raw_affiliation_string":"Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081244924","display_name":"Jaehee Lee","orcid":"https://orcid.org/0000-0003-2519-4828","observed_orcids":["https://orcid.org/0000-0003-2519-4828"]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jaehee Lee","raw_affiliation_strings":["Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States"],"raw_orcid":"https://orcid.org/0000-0003-2519-4828","affiliations":[{"raw_affiliation_string":"Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114147074","display_name":"Lifen Wu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lifen Wu","raw_affiliation_strings":["Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062522093","display_name":"Anjan K. Saha","orcid":"https://orcid.org/0000-0001-6721-1599","observed_orcids":["https://orcid.org/0000-0001-6721-1599"]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anjan K. Saha","raw_affiliation_strings":["Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013446276","display_name":"Guisheng Li","orcid":"https://orcid.org/0000-0002-4522-8936","observed_orcids":["https://orcid.org/0000-0002-4522-8936"]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guisheng Li","raw_affiliation_strings":["Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102982865","display_name":"Yibo Xu","orcid":"https://orcid.org/0000-0002-3418-5387","observed_orcids":["https://orcid.org/0000-0002-3418-5387"]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yibo Xu","raw_affiliation_strings":["Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046820290","display_name":"Zhulin Tan","orcid":"https://orcid.org/0009-0001-6392-0539","observed_orcids":["https://orcid.org/0009-0001-6392-0539"]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhulin Tan","raw_affiliation_strings":["Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081304667","display_name":"Jason Brazzillo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason Brazzillo","raw_affiliation_strings":["Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047441048","display_name":"Nizar Haddad","orcid":"https://orcid.org/0000-0001-7068-7897","observed_orcids":["https://orcid.org/0000-0001-7068-7897"]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nizar Haddad","raw_affiliation_strings":["Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States"],"raw_orcid":"https://orcid.org/0000-0001-7068-7897","affiliations":[{"raw_affiliation_string":"Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029773364","display_name":"Scott J. Pennino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott Pennino","raw_affiliation_strings":["Material and Analytical Sciences, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Material and Analytical Sciences, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102795933","display_name":"Sonia Rodr\u0131\u0301guez","orcid":"https://orcid.org/0000-0003-4892-212X","observed_orcids":["https://orcid.org/0000-0003-4892-212X"]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sonia Rodriguez","raw_affiliation_strings":["Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073947489","display_name":"Jon C. Lorenz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jon C. Lorenz","raw_affiliation_strings":["Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038269289","display_name":"Rogelio P. Frutos","orcid":"https://orcid.org/0000-0002-2065-172X","observed_orcids":["https://orcid.org/0000-0002-2065-172X"]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rogelio Frutos","raw_affiliation_strings":["Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077398160","display_name":"Kanwar P. S. Sidhu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kanwar P. S. Sidhu","raw_affiliation_strings":["Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100346012","display_name":"Xiao\u2010jun Wang","orcid":"https://orcid.org/0000-0002-9403-3502","observed_orcids":["https://orcid.org/0000-0002-9403-3502"]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiao-Jun Wang","raw_affiliation_strings":["Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States"],"raw_orcid":"https://orcid.org/0000-0002-9403-3502","affiliations":[{"raw_affiliation_string":"Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043012629","display_name":"Yongda Zhang","orcid":"https://orcid.org/0000-0002-2575-7590","observed_orcids":["https://orcid.org/0000-0002-2575-7590"]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yongda Zhang","raw_affiliation_strings":["Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States"],"raw_orcid":"https://orcid.org/0000-0002-2575-7590","affiliations":[{"raw_affiliation_string":"Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015397568","display_name":"Chris H. Senanayake","orcid":"https://orcid.org/0009-0009-3170-0687","observed_orcids":["https://orcid.org/0009-0009-3170-0687"]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chris H. Senanayake","raw_affiliation_strings":["Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103380800","display_name":"Jinhua J. Song","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jinhua J. Song","raw_affiliation_strings":["Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States","institution_ids":["https://openalex.org/I4210160255"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5081244924","https://openalex.org/A5083311412"],"corresponding_institution_ids":["https://openalex.org/I4210160255"],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":0.6669,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.58132645,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"26","issue":"9","first_page":"2779","last_page":"2787"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11611","display_name":"Cyclopropane Reaction Mechanisms","score":0.6782000064849854,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11611","display_name":"Cyclopropane Reaction Mechanisms","score":0.6782000064849854,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13649","display_name":"Advanced Synthetic Organic Chemistry","score":0.06159999966621399,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10013","display_name":"Asymmetric Synthesis and Catalysis","score":0.053700000047683716,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mitsunobu-reaction","display_name":"Mitsunobu reaction","score":0.9829999804496765},{"id":"https://openalex.org/keywords/c-n-coupling","display_name":"C\u2013N coupling","score":0.8309999704360962},{"id":"https://openalex.org/keywords/fused-heterocycles","display_name":"fused heterocycles","score":0.6150000095367432},{"id":"https://openalex.org/keywords/scalable-synthesis","display_name":"scalable synthesis","score":0.5400000214576721},{"id":"https://openalex.org/keywords/saponification","display_name":"saponification","score":0.734000027179718},{"id":"https://openalex.org/keywords/active-pharmaceutical-ingredients","display_name":"active pharmaceutical ingredients","score":0.6190000176429749}],"concepts":[{"id":"https://openalex.org/C2779200411","wikidata":"https://www.wikidata.org/wiki/Q80250","display_name":"Cyclopropane","level":3,"score":0.739093005657196},{"id":"https://openalex.org/C502130503","wikidata":"https://www.wikidata.org/wiki/Q1089","display_name":"Palladium","level":3,"score":0.7019044756889343},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6920154690742493},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.5732946395874023},{"id":"https://openalex.org/C2779074116","wikidata":"https://www.wikidata.org/wiki/Q134856","display_name":"Carboxylic acid","level":2,"score":0.5447235703468323},{"id":"https://openalex.org/C75079739","wikidata":"https://www.wikidata.org/wiki/Q1571801","display_name":"Intramolecular force","level":2,"score":0.5294964909553528},{"id":"https://openalex.org/C198503264","wikidata":"https://www.wikidata.org/wiki/Q471635","display_name":"Amination","level":3,"score":0.5286636352539062},{"id":"https://openalex.org/C2779485729","wikidata":"https://www.wikidata.org/wiki/Q210385","display_name":"Pyridine","level":2,"score":0.5175425410270691},{"id":"https://openalex.org/C93237805","wikidata":"https://www.wikidata.org/wiki/Q5375227","display_name":"Enantiopure drug","level":4,"score":0.46101441979408264},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.45697295665740967},{"id":"https://openalex.org/C2779377163","wikidata":"https://www.wikidata.org/wiki/Q899062","display_name":"Mitsunobu reaction","level":2,"score":0.42606109380722046},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.4195074439048767},{"id":"https://openalex.org/C2780378348","wikidata":"https://www.wikidata.org/wiki/Q25351438","display_name":"Ring (chemistry)","level":2,"score":0.16328197717666626},{"id":"https://openalex.org/C146686406","wikidata":"https://www.wikidata.org/wiki/Q898628","display_name":"Enantioselective synthesis","level":3,"score":0.0672566294670105}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1021/acs.oprd.2c00221","doi":"https://doi.org/10.1021/acs.oprd.2c00221","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.oprd.2c00221","pdf_url":null,"source":{"id":"https://openalex.org/S107255770","display_name":"Organic Process Research & Development","issn_l":"1083-6160","issn":["1083-6160","1520-586X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Organic Process Research & Development","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[],"sustainable_development_goals_aurora":[{"display_name":"Industry, innovation and infrastructure","score":0.5699999928474426,"id":"https://metadata.un.org/sdg/9"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W233628489","https://openalex.org/W1990387655","https://openalex.org/W2002738862","https://openalex.org/W2007388923","https://openalex.org/W2041544504","https://openalex.org/W2079660989","https://openalex.org/W2122539442","https://openalex.org/W2144941451","https://openalex.org/W2286054661","https://openalex.org/W2334984477","https://openalex.org/W2760284910","https://openalex.org/W2950341340","https://openalex.org/W2951177323","https://openalex.org/W2952008726","https://openalex.org/W2952820086","https://openalex.org/W2952992178","https://openalex.org/W2970702579","https://openalex.org/W3012421095","https://openalex.org/W3163661307"],"related_works":["https://openalex.org/W2951487134","https://openalex.org/W2951970707","https://openalex.org/W2950294012","https://openalex.org/W2039310452","https://openalex.org/W2732676622","https://openalex.org/W2950267222","https://openalex.org/W2949902493","https://openalex.org/W2782632012","https://openalex.org/W2028279711","https://openalex.org/W2093371237"],"abstract_inverted_index":{"The":[0,43,75,96,111,129],"oxazepane":[1],"pyridine":[2],"intermediate,":[3],"an":[4,148],"important":[5],"fragment":[6],"of":[7,12,30,104,113,143,151],"active":[8],"pharmaceutical":[9,17],"ingredients,":[10],"is":[11,41],"great":[13],"interest":[14],"in":[15,137],"the":[16,28,51,70,83,91,105,120,144],"industry.":[18],"In":[19],"this":[20],"manuscript,":[21],"a":[22,31,46,60,64,138],"scalable":[23],"and":[24,85],"economical":[25],"process":[26,49],"for":[27,59,69],"synthesis":[29,44,112],"fused":[32],"2\u2032,3\u2032-dihydro-5\u2019":[33],"H":[34],"-spiro[cyclopropane-1,4\u2032-pyrido[3,2-b][1,4]oxazepine]-8\u2032-carboxylic":[35],"acid":[36],"1":[37,134],"on":[38],"multikilogram":[39],"scales":[40],"described.":[42],"features":[45],"streamlined":[47],"isolation":[48],"from":[50,123],"Mitsunobu":[52],"reaction":[53,77,122],"by":[54,81,102],"using":[55],"one":[56],"solvent":[57],"system":[58],"two-step":[61],"process.":[62],"Furthermore,":[63],"robust":[65],"palladium-catalyzed":[66],"intramolecular":[67],"amination":[68],"seven-membered":[71],"heterocycle":[72],"was":[73,79,99,117,135],"developed.":[74],"reproducible":[76],"rate":[78],"established":[80],"adding":[82],"catalyst":[84],"ligand":[86],"as":[87],"solids":[88],"without":[89],"preparing":[90],"palladium":[92,98],"complex":[93],"under":[94],"nitrogen.":[95],"residual":[97],"effectively":[100],"reduced":[101],"recrystallization":[103],"carboxylic":[106],"ester":[107,145],"intermediate":[108,115],"2":[109,146],".":[110],"key":[114],"5":[116],"realized":[118],"via":[119],"Kulinkovich":[121],"readily":[124],"available":[125],"simple":[126],"building":[127],"blocks.":[128],"regulatory":[130],"starting":[131],"material":[132],"compound":[133],"isolated":[136],"high-purity":[139],"profile":[140],"after":[141],"saponification":[142],"with":[147],"overall":[149],"yield":[150],"70%":[152],"over":[153],"five":[154],"steps.":[155]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3}],"updated_date":"2026-10-02T10:15:12.560889","created_date":"2022-09-01T00:00:00"}